Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Rhytides: early-phase trial registry
A small indexed set (6 trials) with no open enrollment listed right now.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · none currently recruiting · #2,866 of 28,707 conditions by registered trial count
Rhytides: 6 US clinical trials tracked, none currently recruiting.
Rhytides is the subject of 6 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Lupo Center for Aesthetic and General Dermatology, running 1 of these trials.
Enrollment posture brief
Registry condition rhytides
OPEN 0 | RECR 0% | LATE 0 | EARLY 1 | RANK #2866 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Rhytides has no open enrollment in this registry pull (6 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Rhytides on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Rhytides is recruiting below its size-band peers.
0 of 6 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Rhytides research.
Lupo Center for Aesthetic and General Dermatology accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.
-
Most Rhytides trials plan to enrol fewer than 100 people.
Median target enrolment is 19 among the 6 trials that report a genuine target (sentinel values excluded). 6 of those (100%) plan for fewer than 100 participants.
-
Rhytides research is mostly interventional.
6 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Indexed trials (enrollment closed)
6 total, page 1 of 1
Restylane Refyne for Correction of Horizontal Neck Rhytides
Siperstein Dermatology
NCT04162496
The Cosmetic Effect of Mineral Clay Masks
University of California, Davis
NCT05041465
Randomized, Double-Blind Evaluation of Maple Leaf Extract (Maplifa) for Photoaging
Integrative Skin Science and Research
NCT04586816
Clinical Evaluation of Fractional Radiofrequency for the Treatment and Reduction of Facial Wrinkles
Venus Concept
NCT03831477
Spread of PrabotulinumtoxinA-xvfs Versus OnabotulinumtoxinA in the Treatment of Forehead Rhytides
Lupo Center for Aesthetic and General Dermatology
NCT05807412
Open Label Study Exploring Tissue Histopathology After Ellacor® Procedure in an Abdominoplasty Model.
Cytrellis Biosystems
NCT06421207
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Rhytides records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Rhytides trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Rhytides page
6 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Rhytides trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Lupo Center for Aesthetic and General Dermatology sponsors the most Rhytides trials on record, review their full trial history before evaluating a specific study. See Lupo Center for Aesthetic and General Dermatology's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Rhytides condition card totals 6 registered trials; most-linked intervention vehicle; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.